Zymeworks BC Inc

Zymeworks BC Inc

ZYME

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.08B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Zymeworks BC IncZymeworks BC Inc-14--135%-0.4
$39.80

Target Price by Analysts

33.1% upsideZymeworks BC Target Price DetailsTarget Price
$-18.76

Current Fair Value

162.7% downside

Overvalued by 162.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.08 Billion
Enterprise Value$-144,845,064,547.00
Dividend Yield$- (-)
Earnings per Share$-1.08
Beta1.15
Outstanding Shares72,993,313

Return

Return on Equity-135.41%ROE
Return on Assets-27.41%
Return on Invested Capital-31.87%

Valuation & Multiples

P/E Ratio-14P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio0.03Price to Book Ratio
Enterprise Value to Revenue-57592.47
Enterprise Value to EBIT1.3
Enterprise Value to Net Income1
Total Debt to Enterprise-0.22
Debt to Equity0.4Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 6, 2026
EPS Estimate
$-0.57
Average shareholder expectation
Revenue Estimate
$4.54 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$2.41
Average shareholder expectation
Revenue Estimate
$231.87 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5137▲ 38.65%
Total Calls182,600▼ 58.96%
Total Puts93,800▲ 65.72%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %93.03%▼ 0.25%
Total Invested$1.83B▲ 3.80%
Investors Holding208▼ 13.00%

ESG Score

No data

About Zymeworks Inc

CEO: Ali Tehrani